Siemens’ Sonocur Basic
This article was originally published in The Gray Sheet
Executive Summary
FDA "approvable" letter for the extracorporeal shock wave therapy device is announced June 7. Final PMA approval for lateral epicondylitis (tennis elbow) awaits completion of labeling and FDA inspection of an Erlangen, Germany manufacturing site, the firm says. Sonorex has exclusive, non-hospital U.S. distribution rights...